Gregory D. Gorgas
Net Worth

Last updated:

What is Gregory D. Gorgas net worth?

The estimated net worth of Mr. Gregory D. Gorgas is at least $3,812,640 as of 12 Aug 2022. He owns shares worth $23,400 as insider and has received compensation worth at least $3,789,240 in Artelo Biosciences, Inc..

What is the salary of Gregory D. Gorgas?

Mr. Gregory D. Gorgas salary is $631,540 per year as Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director in Artelo Biosciences, Inc..

How old is Gregory D. Gorgas?

Mr. Gregory D. Gorgas is 62 years old, born in 1963.

What stocks does Gregory D. Gorgas currently own?

As insider, Mr. Gregory D. Gorgas owns shares in one company:

Company Title Shares Price per share Total value
Artelo Biosciences, Inc. (ARTL) Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director 2,400 $9.75 $23,400

What does Artelo Biosciences, Inc. do?

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

ARTL logo
ARTL
Artelo Biosciences, Inc.
$9.75

Gregory D. Gorgas insider trading

Artelo Biosciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 1,200 $4 $4,800
Purchase
Common Stock 1,200 $4.03 $4,836
Purchase
Common Stock 8,500 N/A N/A
Purchase
Warrant (Right to Buy) 1,600 N/A N/A
Purchase
Common Stock 4,200 N/A N/A
Purchase
Common Stock 4,167 N/A N/A
Purchase
Common Stock 2,400 $2.21 $5,304
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 2,500 $2.28 $5,703
Purchase
Common Stock 2,600 $2 $5,187
Purchase
Common Stock 2,600 $2.05 $5,333
Purchase
Common Stock 2,700 N/A N/A

Artelo Biosciences key executives

Artelo Biosciences, Inc. executives and other stock owners filed with the SEC:

  • Mr. Gregory D. Gorgas (62) Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director